Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-08-26
1999-06-08
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
059105011
ABSTRACT:
This invention relates to the manufacture of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and hexahydro-8-hydroxy-2,6-methano-2H-quinolizines and their use as medicaments in the treatment of cognitive disorders.
REFERENCES:
patent: 4845115 (1989-07-01), Tyers
patent: 4906755 (1990-03-01), Gittos
Barnes, et al., Pharmacology Biochem. & Behavior, vol. 35, 955-962 (1990).
Barnes, et al., Neuropharmacology, vol. 29 (11), 1037-1045 (Nov. 1990).
Neuropharmacology, vol. 29, No. 11, Nov. 1990, pp. 1,0237-1,045, Characterisation and Autoradiographic Localisation of 5-HT.sub.3 Receptor Forebrain of the Rat.
Gittos Maurice W.
Hibert Marcel
Gupta Balaram
Henley III Raymond
Merrell Pharmaceuticals Inc.
LandOfFree
Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1683457